Atypical femoral fractures associated with long-term bisphosphonate use.
作者信息
Chatterjee Soumya
出版信息
CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6.
Abstract
摘要
相似文献
1
Atypical femoral fractures associated with long-term bisphosphonate use.
CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6.
2
Atypical femoral fractures: a complication of prolonged bisphosphonate therapy?
Med J Aust. 2011 Jan 17;194(2):102-3; author reply 103. doi: 10.5694/j.1326-5377.2011.tb04181.x.
3
Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.
Rheumatology (Oxford). 2014 Oct;53(10):1911-3. doi: 10.1093/rheumatology/keu286. Epub 2014 Aug 6.
4
Evolving data about subtrochanteric fractures and bisphosphonates.
N Engl J Med. 2010 May 13;362(19):1825-7. doi: 10.1056/NEJMe1003064. Epub 2010 Mar 24.
5
Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Singapore Med J. 2012 Mar;53(3):e52-4.
6
Atypical fractures of the femur and ulna and complications of fracture healing in a 76-year-old woman with Sjögren's syndrome.
J Musculoskelet Neuronal Interact. 2011 Jun;11(2):208-11; quiz 211.
7
Atypical proximal femoral fractures in patients with paget disease receiving bisphosphonate therapy.
AJR Am J Roentgenol. 2011 Jul;197(1):W196-7. doi: 10.2214/AJR.10.6343.
8
Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy.
Rheumatol Int. 2011 Jul;31(7):973-5. doi: 10.1007/s00296-010-1477-3. Epub 2010 Apr 10.
9
Atypical femur fractures: a complication of prolonged bisphosphonate therapy?
Med J Aust. 2010 Aug 16;193(4):196-8. doi: 10.5694/j.1326-5377.2010.tb03865.x.
10
Femoral stress fractures associated with long-term bisphosphonate treatment.
Clin Orthop Relat Res. 2012 Mar;470(3):759-65. doi: 10.1007/s11999-011-2194-2.
引用本文的文献
1
Interval Training Is Not Superior to Endurance Training With Respect to Bone Accrual of Ovariectomized Mice.
Front Physiol. 2020 Sep 9;11:1096. doi: 10.3389/fphys.2020.01096. eCollection 2020.
2
Caveats of bisphosphonate abuse.
Indian J Orthop. 2016 Jul-Aug;50(4):434-9. doi: 10.4103/0019-5413.185612.
本文引用的文献
1
Atypical femoral fracture risk in patients treated with bisphosphonates.
Arch Intern Med. 2012 Jun 25;172(12):936-7. doi: 10.1001/archinternmed.2012.1827.
2
Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
Arch Intern Med. 2012 Jun 25;172(12):930-6. doi: 10.1001/archinternmed.2012.1796.
3
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927.
Zotero 插件